Author name: TB Alliance

“Public-private partnerships have adopted business models that exploit the venture capital approach to investment in new product R&D…The commitment of

American Society for Microbiology 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (Washington, DC, Oct 31, 2004) The

Enlisting government participation and commitment to new drugs is at the core of the TB Alliance’s design as a public-private

TB Alliance is teaming up with the newly launched European and Developing Countries Clinical Trials Partnership (EDCTP) to enhance clinical

A lead compound in the TB Alliance portfolio, PA-824, recently showed additional promise as a potential TB drug in studies

From The New York Times – July 16, 2004By Lawrence K. Altman BANGKOK, July 15 – Nelson Mandela came to

From Reuters – July 15, 2004 BANGKOK (Reuters) – The global war on AIDS could be lost if the world

“We cannot win the battle against AIDS if we do not also fight TB. TB is too often a death

Novartis’ participation to the fight against TB rests on two key principles shared by the TB Alliance. The core scientific